175 related articles for article (PubMed ID: 36269841)
1. Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice.
Mazharian A; Maître B; Bornert A; Hennequin D; Lourenco-Rodrigues M; Geer MJ; Smith CW; Heising S; Walter M; Montel F; Walker LSK; de la Salle H; Watson SP; Gachet C; Senis YA
Blood Adv; 2023 Jan; 7(1):46-59. PubMed ID: 36269841
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.
Mazharian A; Wang YJ; Mori J; Bem D; Finney B; Heising S; Gissen P; White JG; Berndt MC; Gardiner EE; Nieswandt B; Douglas MR; Campbell RD; Watson SP; Senis YA
Sci Signal; 2012 Oct; 5(248):ra78. PubMed ID: 23112346
[TBL] [Abstract][Full Text] [Related]
3. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
[TBL] [Abstract][Full Text] [Related]
5. G6b-B regulates an essential step in megakaryocyte maturation.
Becker IC; Nagy Z; Manukjan G; Haffner-Luntzer M; Englert M; Heib T; Vögtle T; Gross C; Bharti R; Dietrich S; Mott K; Heck J; Stegmaier S; Baranowsky A; Schinke T; Schlegel N; Heckel T; Stegner D; Pleines I; Ignatius A; Schulze H; Nieswandt B
Blood Adv; 2022 May; 6(10):3155-3161. PubMed ID: 35134123
[TBL] [Abstract][Full Text] [Related]
6. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
[TBL] [Abstract][Full Text] [Related]
7. Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets.
Smith CW; Thomas SG; Raslan Z; Patel P; Byrne M; Lordkipanidzé M; Bem D; Meyaard L; Senis YA; Watson SP; Mazharian A
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):823-835. PubMed ID: 28336561
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2.
Inoue O; Suzuki-Inoue K; Dean WL; Frampton J; Watson SP
J Cell Biol; 2003 Mar; 160(5):769-80. PubMed ID: 12615912
[TBL] [Abstract][Full Text] [Related]
10. α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis.
Marjoram RJ; Li Z; He L; Tollefsen DM; Kunicki TJ; Dickeson SK; Santoro SA; Zutter MM
PLoS One; 2014; 9(11):e114035. PubMed ID: 25415203
[TBL] [Abstract][Full Text] [Related]
11. Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD.
Léon C; Evert K; Dombrowski F; Pertuy F; Eckly A; Laeuffer P; Gachet C; Greinacher A
Blood; 2012 Apr; 119(14):3333-41. PubMed ID: 22234693
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
Vögtle T; Sharma S; Mori J; Nagy Z; Semeniak D; Scandola C; Geer MJ; Smith CW; Lane J; Pollack S; Lassila R; Jouppila A; Barr AJ; Ogg DJ; Howard TD; McMiken HJ; Warwicker J; Geh C; Rowlinson R; Abbott WM; Eckly A; Schulze H; Wright GJ; Mazharian A; Fütterer K; Rajesh S; Douglas MR; Senis YA
Elife; 2019 Aug; 8():. PubMed ID: 31436532
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein VI/Fc receptor gamma chain-independent tyrosine phosphorylation and activation of murine platelets by collagen.
Jarvis GE; Best D; Watson SP
Biochem J; 2004 Nov; 383(Pt. 3):581-8. PubMed ID: 15283702
[TBL] [Abstract][Full Text] [Related]
14. Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice.
Schuhmann MK; Kraft P; Bieber M; Kollikowski AM; Schulze H; Nieswandt B; Pham M; Stegner D; Stoll G
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022936
[TBL] [Abstract][Full Text] [Related]
15. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
Suzuki-Inoue K; Inoue O; Frampton J; Watson SP
Blood; 2003 Aug; 102(4):1367-73. PubMed ID: 12730118
[TBL] [Abstract][Full Text] [Related]
16. G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.
Mazharian A; Bertin O; Sarkar A; Augros J; Bornert A; Loubière C; Jönsson F; Warwicker J; Abbott WM; Dushek O; Vayne C; Rauova L; Fütterer K; Rollin J; Poncz M; Senis YA
bioRxiv; 2024 May; ():. PubMed ID: 38798354
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
[TBL] [Abstract][Full Text] [Related]
18. GPVI signaling is compromised in newly formed platelets after acute thrombocytopenia in mice.
Gupta S; Cherpokova D; Spindler M; Morowski M; Bender M; Nieswandt B
Blood; 2018 Mar; 131(10):1106-1110. PubMed ID: 29295843
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type.
Jooss NJ; Henskens YMC; Watson SP; Farndale RW; Gawaz MP; Jandrot-Perrus M; Poulter NS; Heemskerk JWM
Thromb Haemost; 2023 Jun; 123(6):597-612. PubMed ID: 36807826
[TBL] [Abstract][Full Text] [Related]
20. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
